View Item 

Show simple item record

Drug-associated histiocytoid Sweet’s syndrome: a true neutrophilic maturation arrest variant
dc.contributor.authorWu, Angela J.en_US
dc.contributor.authorRodgers, Timothyen_US
dc.contributor.authorFullen, Douglas R.en_US
dc.date.accessioned2010-06-01T20:51:53Z
dc.date.available2010-06-01T20:51:53Z
dc.date.issued2008-02en_US
dc.identifier.citationWu, Angela J.; Rodgers, Timothy; Fullen, Douglas R. (2008). "Drug-associated histiocytoid Sweet’s syndrome: a true neutrophilic maturation arrest variant." Journal of Cutaneous Pathology 35(2): 220-224. <http://hdl.handle.net/2027.42/73962>en_US
dc.identifier.issn0303-6987en_US
dc.identifier.issn1600-0560en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73962
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18300386&dopt=citationen_US
dc.format.extent456048 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsBlackwell Munksgaard 2007en_US
dc.titleDrug-associated histiocytoid Sweet’s syndrome: a true neutrophilic maturation arrest varianten_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Dermatology, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartment of Pathologyen_US
dc.identifier.pmid18300386en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73962/1/j.1600-0560.2007.00780.x.pdf
dc.identifier.doi10.1111/j.1600-0560.2007.00780.xen_US
dc.identifier.sourceJournal of Cutaneous Pathologyen_US
dc.identifier.citedreferenceCohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol 2003; 42: 761.en_US
dc.identifier.citedreferenceRequena L, Kutzner H, Palmedo G, et al. Histiocytoid sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol 2005; 141: 834.en_US
dc.identifier.citedreferenceMasters P, O’Bryan T, Zurlo J, Miller D, Joshi N. Trimethoprim-sulfamethoxazole revisited. Arch Intern Med 2003; 163: 402.en_US
dc.identifier.citedreferenceAndres E, Kurtz JE, Maloisel F. Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985–2000) and review of the literature. Clin Lab Haematol 2002; 24: 99.en_US
dc.identifier.citedreferenceWalker D, Cohen P. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol 1996; 34: 918.en_US
dc.identifier.citedreferenceKawakami T, Syuichiro O, Kawa Y, et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of Sweet syndrome and patients with active Behcet disease. Arch Dermatol 2004; 140: 570.en_US
dc.identifier.citedreferenceAvalos B, Gasson J, Hedvat C, et al. Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood 1990; 75: 851.en_US
dc.identifier.citedreferencePhilpott NJ, Prue RL, Marsh JC, Gordon-Smith EC, Gibson FM. G-CSF-mobilized CD34+ peripheral blood stem cells are significantly less apoptotic than unstimulated peripheral blood CD34+ cells: role of G-CSF as survival factor. Br J Haematol 1997; 97: 146.en_US
dc.identifier.citedreferenceKavgaci H, Ozdemir F, Aydin F, Yavuz A, Yavuz M. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases. J Exp Clin Cancer Res 2002; 21: 475.en_US
dc.identifier.citedreferenceArbetter KR, Hubbard KW, Markovic SN, Gibson LE, Phyliky RL. Case of granulocyte colony-stimulating factor-induced Sweet’s syndrome. Am J Hematol 1999; 61: 126.en_US
dc.identifier.citedreferenceFukutoku M, Shimizu S, Ogawa Y, et al. Sweet’s syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia. Br J Haematol 1994; 86: 645.en_US
dc.identifier.citedreferenceHasegawa M, Sato S, Nakada M, et al. Sweet’s syndrome associated with granulocyte colony-stimulating factor. Eur J Dermatol 1998; 8: 503.en_US
dc.identifier.citedreferencePrevost-Blank PL, Shwayder TA. Sweet’s syndrome secondary to granulocyte colony-stimulating factor. J Am Acad Dermatol 1996; 35: 995.en_US
dc.identifier.citedreferenceRichard M, Grob J, Laurans R, et al. Sweet’s syndrome induced by granulocyte colony-stimulating factor in a woman with congenital neutropenia. J Am Acad Dermatol 1996; 35: 629.en_US
dc.identifier.citedreferenceWhite J, Mufti G, Salisbury J, du Vivier A. Cutaneous manifestations of granulocyte colony-stimulating factor. Clin Exp Dermatol 2006; 31: 206.en_US
dc.identifier.citedreferenceMagro CM, De Moraes E, Burns F. Sweet’s syndrome in the setting of CD34-positive acute myelogenous leukemia treated with granulocyte colony stimulating factor: evidence for a clonal neutrophilic dermatosis. J Cutan Pathol 2001; 28: 90.en_US
dc.identifier.citedreferenceDereure O, Hillaire-Buys D, Guilhou J. Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome? Br J Dermatol 2004; 150: 1228.en_US
dc.identifier.citedreferenceJohnston B, Kubes P. The Α4integrin: an alternative pathway for neutrophil recruitment? Immunol Today 1999; 20: 545.en_US
dc.identifier.citedreferenceSpiekermann K, Roesler J, Emmendoerffer A, Elsner J, Welte K. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia 1997; 11: 466.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-0560.2007.00780.x.pdf
Size:
445.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.